On June 27, Hyperliquid Strategies rose 8.29% in regular trading, trading at $8.685/share, with turnover of $58.72 million. The rally represents an oversold recovery following the digestion of sustained selling pressure from large-scale HYPE token unlocks.
On the news front, HYPE token unlocks had previously triggered persistent supply shocks, dragging the stock from its high of $11.69 down over 35% to a low of $7.55. With that selling pressure now largely absorbed, the stock entered a technical rebound phase. Fundamentally, Chardan previously raised its price target to $9.75 from $8.45 while maintaining a Buy rating. Multiple institutions have noted that Hyperliquid's perpetual DEX commands a 31.9% market share, the platform generates over $600 million in annual revenue, and its valuation stands at roughly half that of traditional exchange CME, suggesting significant undervaluation.
Additionally, the company has been actively accumulating HYPE tokens, purchasing 220,000 tokens worth approximately $8.58 million since March, and currently holds 18.82 million HYPE tokens valued at approximately $738 million.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments